Home/Filings/4/0001610618-24-000025
4//SEC Filing

Tari Leslie 4

Accession 0001610618-24-000025

CIK 0001610618other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 6:47 PM ET

Size

7.9 KB

Accession

0001610618-24-000025

Insider Transaction Report

Form 4
Period: 2024-03-15
Tari Leslie
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-03-15+222,500222,500 total
    Exercise: $0.68Exp: 2034-03-14Common Stock (222,500 underlying)
  • Award

    Common Stock

    2024-03-15+111,250369,931 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    1,484
Footnotes (2)
  • [F1]Represents time-based Restricted Stock Units (RSUs) granted on March 15, 2024. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2025, 2026, and 2027, subject to continuous service through each such vesting date.
  • [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 15, 2024.

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1
  • filerCIK 0001870270

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:47 PM ET
Size
7.9 KB